Viewing Study NCT02987166


Ignite Creation Date: 2025-12-24 @ 4:04 PM
Ignite Modification Date: 2025-12-27 @ 6:24 AM
Study NCT ID: NCT02987166
Status: COMPLETED
Last Update Posted: 2020-12-16
First Post: 2016-11-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: HDCRT Plus Pembrolizumab in Advanced Malignancies
Sponsor: James Larner, MD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module